Challenge
At the start of the collaboration, our client requested support in introducing one of their Phase I assets to the Liberi network and assisting with out-licensing to pharmaceutical companies.
Process
After conducting the kick-off meeting, during which we learned about the partnering strategy for the mentioned asset, Liberi created a list of potentially interested companies for our client to review. After discussing the feedback and agreeing on a final list, Liberi began introducing the asset to the highlighted companies. Responses from the industry followed, showing great interest in the project. Within three weeks of starting the outreach, multiple introduction meetings were scheduled. The large list of potentially interested companies was narrowed down to a smaller group that requested to conduct a confidential review of the project, followed by draft term sheets.
During one of the update meetings, our client expressed a high level of satisfaction with the leads that Liberi was able to generate. As a result, they asked if we could provide our services for their lead asset as well. A new list of potentially interested companies was created and reviewed by our client. Similar to the first asset, the large list was eventually narrowed down to a smaller group of interested companies. This time, many responses contained messages similar to: “We would like to await future clinical data.”
Although this feedback was promising, there was still an urgent need to secure a collaboration as soon as possible. Thanks to Liberi’s active involvement in various conferences and networking platforms, we were able to establish contact with a pharmaceutical company that was new to our network.
Result
After gaining permission from our client, the lead asset was introduced to the company, followed by a (non-)confidential review. Within two months, the pharmaceutical company submitted a draft term sheet.
This business case demonstrates that when there is industry interest, Liberi can achieve results quickly and facilitate confidential reviews within weeks.
Get in touch